Safety and feasibility of single-port laparoscopic low anterior resection for upper rectal cancer
Single-port surgery for rectal cancer is challenging and controversial. The aim of this study was to compare the short-term outcomes of single-port laparoscopic low anterior resection (S-LAR) to multi-port laparoscopic low anterior resection (M-LAR) for upper rectal cancer. From January 2011 to Dece...
Saved in:
Published in | The American journal of surgery Vol. 216; no. 6; pp. 1101 - 1106 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Single-port surgery for rectal cancer is challenging and controversial. The aim of this study was to compare the short-term outcomes of single-port laparoscopic low anterior resection (S-LAR) to multi-port laparoscopic low anterior resection (M-LAR) for upper rectal cancer.
From January 2011 to December 2015, a total of 93 patients who underwent S-LAR (n = 44) or M-LAR (n = 49) without protective diverting ileostomy for upper rectal cancer were identified. Tumors were located between the inferior margin of the second sacral vertebra and the peritoneal reflection. Short-term outcomes were compared between groups.
S-LAR was successful in 75% of cases: 25% of cases required one additional port. Operative factors, perioperative outcomes, oncological outcomes did not differ significantly between groups. In patients with stage I-III disease, the 3-year relapse-free survival rate was significantly higher in the S-LAR group than in the M-LAR group (p = 0.032). The 3-year overall survival rate was similar between groups.
S-LAR is safe, feasible and can provide satisfactory oncological outcomes in selected patients with upper rectal cancer.
•We assess the safety and feasibility of S-LAR for upper rectal cancer.•Short-term and long-term oncological outcomes did not differ significantly between S-LAR and M-LAR group.•S-LAR is safe, feasible and can provide satisfactory oncological outcomes in selected patients with upper rectal cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0002-9610 1879-1883 |
DOI: | 10.1016/j.amjsurg.2018.03.022 |